Assessment of Adverse Events in Protocols, Clinical Study Reports, and Published Papers of Trials of Orlistat: A Document Analysis.
Schroll, Jeppe Bennekou; Penninga, Elisabeth I; Gøtzsche, Peter C.
; 13(8): e1002101, 2016 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-27529343
Drug interventions for the treatment of obesity in children and adolescents.
Study on health hazards through medicines purchased on the Internet: a cross-sectional investigation of the quality of anti-obesity medicines containing crude drugs as active ingredients.
Treatment of obesity with celastrol.
Improvement of plasma adiponectin, leptin and C-reactive protein concentrations by orlistat: a systematic review and meta-analysis.
Long-term drug treatment for obesity: a systematic and clinical review.
Reporting of harms outcomes: a comparison of journal publications with unpublished clinical study reports of orlistat trials.
Weight reduction for non-alcoholic fatty liver disease.
Dose-ranging study of an orlistat tablet formulation.
Usage of Plant Food Supplements (PFS) for weight control in six European countries: results from the PlantLIBRA PFS Consumer Survey 2011-2012.
Total synthesis of tetrahydrolipstatin and stereoisomers via a highly regio- and diastereoselective carbonylation of epoxyhomoallylic alcohols.